Max Zeller Söhne AG
Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efficacy, safety and tolerability.
Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to finished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients benefit from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.
Debiopharm International SA
Dr Fabien Sebille
Director Business Development, Licensing Marketing & CommunicationDr Fabrice Paradies
Director Industrial Business Develpment & Global Commercial AlliancesVifor Pharma
Mrs Gabrielle Gache
Head BD&L SwitzerlandDr Roland Pfeiffer
Head of Commercial Development EuropePMC Pharma Management Consultants GmbH
We are a deal broker and M&A advisory boutique that is specializing in transactions in the corporate sector of the pharmaceutical and healthcare industry and the consumer goods industry.
We support our clients in
- Purchase and sale of companies and participations
- Purchase and sale of brands and product portfolios
- Business cooperations
We carry out targeted searches for transaction opportunities worldwide and support our clients in all phases of the M&A process.
Due to our long experience in this field and our continuously updated network of more than 40,000 strategic and financial investors worldwide we are able to quickly identify suitable investors and/or targets and complete transactions discreetly and reliably.